236 related articles for article (PubMed ID: 25780025)
21. Cortical involvement in Marchiafava-Bignami disease.
Johkura K; Naito M; Naka T
AJNR Am J Neuroradiol; 2005 Mar; 26(3):670-3. PubMed ID: 15760886
[TBL] [Abstract][Full Text] [Related]
22. MR imaging in the diagnosis of Marchiafava-Bignami syndrome.
Tembey RA; Karnik A; Mani SA
Neurol India; 2019; 67(1):321-323. PubMed ID: 30860152
[No Abstract] [Full Text] [Related]
23. Teaching neuroimages: radiologic findings in Marchiafava-Bignami disease.
Tozakidou M; Stippich C; Fischmann A
Neurology; 2011 Sep; 77(11):e67. PubMed ID: 21911733
[No Abstract] [Full Text] [Related]
24. Acute Marchiafava-Bignami disease with extensive diffusion restriction and early recovery: case report and review of the literature.
Wenz H; Eisele P; Artemis D; Förster A; Brockmann MA
J Neuroimaging; 2014; 24(4):421-4. PubMed ID: 23253188
[TBL] [Abstract][Full Text] [Related]
25. Depression preceding Marchiafava-Bignami disease.
Zhen NB; Gaillard F; Walterfang M; Mohd Zain NR; Yoon CK
Aust N Z J Psychiatry; 2021 Feb; 55(2):224-225. PubMed ID: 32720512
[No Abstract] [Full Text] [Related]
26. Reversible corpus callosum lesions in a patient with Marchiafava-Bignami disease: serial changes on MRI.
Yamashita K; Kobayashi S; Yamaguchi S; Koide H; Nishi K
Eur Neurol; 1997; 37(3):192-3. PubMed ID: 9137933
[No Abstract] [Full Text] [Related]
27. Marchiafava-Bigmani disease in relation to pure alcohol consumption.
Sena P; Nzwalo H; Ferreira F; Drago J; Soleiro L
J Neuropsychiatry Clin Neurosci; 2013; 25(2):E71-2. PubMed ID: 23686077
[No Abstract] [Full Text] [Related]
28. Corticosteroid treatment in a patient with Marchiafava-Bignami disease.
Consoli A; Pirritano D; Bosco D; Postorino P; Consoli D
Neurol Sci; 2014 Jul; 35(7):1143-5. PubMed ID: 24609940
[No Abstract] [Full Text] [Related]
29. Marchiafava-Bignami disease: Two cases with magnetic resonance imaging and positron emission tomography scan findings.
Nalini A; Kovoor JM; Dawn R; Kallur KG
Neurol India; 2009; 57(5):644-8. PubMed ID: 19934569
[TBL] [Abstract][Full Text] [Related]
30. Paucisymptomatic Marchiafava-Bignami disease with relevant diffusion-weighted MRI lesions.
Sarpa MG; Ferrazzoli D; Massa R; Garaci F; Izzi F; Romigi A; Liguori C; Placidi F
Int J Neurosci; 2013 Oct; 123(10):738-40. PubMed ID: 23638646
[TBL] [Abstract][Full Text] [Related]
31. Marchiafava-Bignami disease: An acquired callosotomy.
Lakatos A; Kosta P; Konitsiotis S; Zikou AK; Astrakas LG; Argyropoulou MI
Neurology; 2014 Sep; 83(13):1219. PubMed ID: 25253877
[No Abstract] [Full Text] [Related]
32. Altered sensorium in a chronic alcoholic: pancreatic encephalopathy, Wernicke's encephalopathy or Marchiafava Biganami disease?
Gupta R; Das S; Gupta R; Ahuja V; Saini M; Dhyani M
Trop Gastroenterol; 2015; 36(4):266-8. PubMed ID: 27509707
[No Abstract] [Full Text] [Related]
33. Marchiafava-Bignami disease: magnetic resonance imaging findings in corpus callosum and subcortical white matter.
Kawarabuki K; Sakakibara T; Hirai M; Yoshioka Y; Yamamoto Y; Yamaki T
Eur J Radiol; 2003 Nov; 48(2):175-7. PubMed ID: 14680909
[TBL] [Abstract][Full Text] [Related]
34. Marchiafava-Bignami disease: diffusion-weighted MRI in corpus callosum and cortical lesions.
Khaw AV; Heinrich A
Neurology; 2006 Apr; 66(8):1286; author reply 1286. PubMed ID: 16636264
[No Abstract] [Full Text] [Related]
35. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases.
Hillbom M; Saloheimo P; Fujioka S; Wszolek ZK; Juvela S; Leone MA
J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):168-73. PubMed ID: 23978380
[TBL] [Abstract][Full Text] [Related]
36. Cortical involvement in Marchiafava-Bignami disease can be a predictor of a poor prognosis: a case report and review of the literature.
Namekawa M; Nakamura Y; Nakano I
Intern Med; 2013; 52(7):811-3. PubMed ID: 23545681
[TBL] [Abstract][Full Text] [Related]
37. [Marchiafava-Bignami disease].
Gao X; Wang C; Liu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Aug; 16(4):309-11. PubMed ID: 7867101
[TBL] [Abstract][Full Text] [Related]
38. [Reversible demyelinisation of corpus callosum in the course of Marchiafava-Bignami disease].
Staszewski J; Macek K; Stepień A
Neurol Neurochir Pol; 2006; 40(2):156-61. PubMed ID: 16628513
[TBL] [Abstract][Full Text] [Related]
39. Corpus callosum fibre disruption in Marchiafava-Bignami disease.
Bhat A; Punia V; Lee HJ; Marks D
Pract Neurol; 2014 Jun; 14(3):189-90. PubMed ID: 24127610
[No Abstract] [Full Text] [Related]
40. Acute Marchiafava-Bignami disease: diffusion-weighted MRI in cortical and callosal involvement.
Ihn YK; Hwang SS; Park YH
Yonsei Med J; 2007 Apr; 48(2):321-4. PubMed ID: 17461534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
